<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9326236" created="05/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9326236</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="interleukin-7" sem="Protein_molecule">Interleukin-7</term> upregulates the <term id="T2" lex="interleukin-2-gene_expression" sem="Other"><term id="T3" lex="interleukin-2-gene" sem="DNA_domain_or_region">interleukin-2-gene</term> expression</term> in <term id="T4" lex="activated_human_T_lymphocyte" sem="Cell_natural">activated human <term id="A12" sem="Cell_natural">T lymphocytes</term></term> at the transcriptional level by enhancing the <term id="T5" lex="DNA_binding_activity" sem="Other"><term id="A1" sem="DNA_domain_or_region">DNA</term> binding activities</term> of both <term id="A2" sem="Protein_family_or_group">nuclear factor of <term id="T6" lex="activated_T_cell" sem="Cell_natural">activated T cells</term></term> and <term id="T7" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="E4"/>
<clue>Interleukin-7 <clueType>upregulates</clueType> the interleukin-2-gene expression <clueLoc>in activated human T lymphocytes</clueLoc> at the transcriptional level <linkCause>by</linkCause> enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="E5"/>
<clue>Interleukin-7 <clueType>upregulates</clueType> the interleukin-2-gene expression <clueLoc>in activated human T lymphocytes</clueLoc> at the transcriptional level <linkCause>by</linkCause> enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E3">
<type class="Transcription"/>
<theme idref="T3"/>
<clue>Interleukin-7 upregulates the interleukin-2-gene <clueType>expression</clueType> in activated human T lymphocytes <clueType>at the transcriptional level</clueType> by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E4">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T1"/>
<clue>Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by <clueType>enhancing</clueType> the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T1"/>
<clue>Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by <clueType>enhancing</clueType> the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E6">
<type class="Binding"/>
<theme idref="A1"/>
<theme idref="A2"/>
<clue>Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA <clueType>binding</clueType> activities <linkTheme>of</linkTheme> both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E7">
<type class="Binding"/>
<theme idref="T7"/>
<theme idref="A1"/>
<clue>Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA <clueType>binding</clueType> activities <linkTheme>of</linkTheme> both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
<event id="E48">
<type class="Physiological_process"/>
<theme idref="A12"/>
<clue>Interleukin-7 upregulates the interleukin-2-gene expression in <clueType>activated</clueType> human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In the present report, we studied the role of the <term id="T8" lex="stromal-derived_cytokine_interleukin-7" sem="Protein_molecule"><term id="T9" lex="stromal-derived_cytokine" sem="Protein_family_or_group">stromal-derived cytokine</term> <term id="T10" lex="interleukin-7" sem="Protein_molecule">interleukin-7</term></term> (<term id="T11" lex="IL-7" sem="Protein_molecule">IL-7</term>) in the <term id="T12" lex="IL-2-gene_regulation" sem="Other"><term id="T13" lex="IL-2-gene" sem="DNA_domain_or_region">IL-2-gene</term> regulation</term> in activated <term id="A3" sem="Cell_natural">T lymphocytes</term>.</sentence>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="T11"/>
<clue>In the present report, we <clueKT>studied</clueKT> the <clueType>role</clueType> <linkCause>of</linkCause> the stromal-derived cytokine interleukin-7 (IL-7) <linkTheme>in</linkTheme> the IL-2-gene regulation in activated T lymphocytes.</clue>
</event>
<event KT="Other" id="E9">
<type class="Regulation"/>
<theme idref="T13"/>
<clue>In the present report, we studied the role of the stromal-derived cytokine interleukin-7 (IL-7) in the IL-2-gene <clueType>regulation</clueType> <clueLoc>in activated T lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E10">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue>In the present report, we studied the role of the stromal-derived cytokine interleukin-7 (IL-7) in the IL-2-gene regulation in <clueType>activated</clueType> T lymphocytes.</clue>
</event>
<sentence id="S3">Production of <term id="T15" lex="IL-2" sem="Protein_molecule">IL-2</term> requires the formation of <term id="T16" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> involved in the <term id="T17" lex="IL-2-gene_regulation" sem="Other"><term id="T18" lex="IL-2-gene" sem="DNA_domain_or_region"><term id="T19" lex="IL-2" sem="Protein_molecule">IL-2</term>-gene</term> regulation</term>.</sentence>
<event KT="Other" id="E11">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue><clueType>Production</clueType> <linkTheme>of</linkTheme> IL-2 requires the formation of transcription factors involved in the IL-2-gene regulation.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="E13"/>
<clue>Production of IL-2 <clueType>requires</clueType> the formation of transcription factors involved in the IL-2-gene regulation.</clue>
</event>
<event KT="Other" id="E13">
<type class="Protein_metabolism"/>
<theme idref="T16"/>
<clue>Production of IL-2 requires the <clueType>formation</clueType> <linkTheme>of</linkTheme> transcription factors involved in the IL-2-gene regulation.</clue>
</event>
<event KT="Other" id="E14">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="T16"/>
<clue>Production of IL-2 requires the formation of transcription factors <clueType>involved</clueType> <linkTheme>in</linkTheme> the IL-2-gene regulation.</clue>
</event>
<event KT="Other" id="E15">
<type class="Regulation"/>
<theme idref="T18"/>
<clue>Production of IL-2 requires the formation of transcription factors involved in the IL-2-gene <clueType>regulation</clueType>.</clue>
</event>
<sentence id="S4"><term id="T20" lex="T-cell_receptor_(TCR)/CD3_engagement" sem="Other"><term id="T21" lex="T-cell_receptor" sem="Protein_family_or_group">T-cell receptor</term> (<term id="A4" sem="Protein_family_or_group">TCR</term>)/<term id="A5" sem="Protein_molecule">CD3</term> engagement</term> results in the <term id="T22" sem="Other">activation</term> of <term id="T23" sem="Protein_family_or_group">nuclear factor</term> of activated <term id="T39" sem="Cell_natural">T cells</term> (<term id="T24" lex="NFAT" sem="Protein_family_or_group">NFAT</term>), <term id="T25" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term> (<term id="T26" lex="AP-1" sem="Protein_molecule">AP-1</term>), and <term id="T27" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T28" lex="NFkappaB" sem="Protein_complex">NFkappaB</term>), whereas the <term id="T29" lex="CD28_responsive_complex" sem="Protein_complex">CD28 responsive complex</term> (<term id="T30" lex="CD28RC" sem="Protein_complex">CD28RC</term>) is activated in response to the <term id="T31" lex="CD28_signal" sem="Other"><term id="T32" lex="CD28" sem="Protein_molecule">CD28</term> signal</term>.</sentence>
<event id="E16">
<type class="Binding"/>
<theme idref="A4"/>
<theme idref="A5"/>
<clue>T-cell receptor (TCR)/CD3 <clueType>engagement</clueType> results in the activation of nuclear factor of activated T cells (NFAT), activator protein-1 (AP-1), and nuclear factor kappaB (NFkappaB), whereas the CD28 responsive complex (CD28RC) is activated in response to the CD28 signal.</clue>
<comment>NER: T22 del, &quot;(TCR)/CD3&quot;</comment></event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<cause idref="E16"/>
<clue>T-cell receptor (TCR)/CD3 engagement results in the <clueType>activation</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells (NFAT), activator protein-1 (AP-1), and nuclear factor kappaB (NFkappaB), whereas the CD28 responsive complex (CD28RC) is activated in response to the CD28 signal.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="E16"/>
<clue>T-cell receptor (TCR)/CD3 engagement results in the <clueType>activation</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells (NFAT), activator protein-1 (AP-1), and nuclear factor kappaB (NFkappaB), whereas the CD28 responsive complex (CD28RC) is activated in response to the CD28 signal.</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="E16"/>
<clue>T-cell receptor (TCR)/CD3 engagement results in the <clueType>activation</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells (NFAT), activator protein-1 (AP-1), and nuclear factor kappaB (NFkappaB), whereas the CD28 responsive complex (CD28RC) is activated in response to the CD28 signal.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="T32"/>
<clue>T-cell receptor (TCR)/CD3 engagement results in the activation of nuclear factor of activated T cells (NFAT), activator protein-1 (AP-1), and nuclear factor kappaB (NFkappaB), whereas the CD28 responsive complex (CD28RC) is <clueType>activated</clueType> <linkCause>in response to</linkCause> the CD28 signal.</clue>
</event>
<sentence id="S5">Costimulation of <term id="T33" lex="phytohemagglutinin/anti-CD28_activated_T_lymphocyte" sem="Cell_cultured"><term id="T34" lex="phytohemagglutinin" sem="Protein_molecule">phytohemagglutinin</term>/<term id="A6" sem="Protein_molecule">anti-CD28</term> activated <term id="A7" sem="Cell_natural">T lymphocytes</term></term> with <term id="T36" lex="IL-7" sem="Protein_molecule">IL-7</term> induces a fivefold enhanced <term id="T37" lex="IL-2-mRNA_accumulation" sem="Other"><term id="A13" sem="RNA_molecule"><term id="T38" lex="IL-2" sem="Protein_molecule">IL-2</term>-mRNA</term> accumulation</term> and a 2.5-fold enhanced <term id="T14" sem="Other">protein secretion</term>.</sentence>
<event id="E21">
<type class="Physiological_process"/>
<theme idref="E22"/>
<theme idref="E47"/>
<cause idref="T36"/>
<clue><clueType>Costimulation</clueType> <linkTheme>of</linkTheme> phytohemagglutinin/anti-CD28 activated T lymphocytes <linkCause>with</linkCause> IL-7 induces a fivefold enhanced IL-2-mRNA accumulation and a 2.5-fold enhanced protein secretion.</clue>
</event>
<event id="E22">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="T34"/>
<clue>Costimulation of phytohemagglutinin/anti-CD28 <clueType>activated</clueType> T lymphocytes with IL-7 induces a fivefold enhanced IL-2-mRNA accumulation and a 2.5-fold enhanced protein secretion.</clue>
</event>
<event id="E47">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="A6"/>
<clue>Costimulation of phytohemagglutinin/anti-CD28 <clueType>activated</clueType> T lymphocytes with IL-7 induces a fivefold enhanced IL-2-mRNA accumulation and a 2.5-fold enhanced protein secretion.</clue>
</event>
<event Manner="High" id="E23">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E21"/>
<clue>Costimulation of phytohemagglutinin/anti-CD28 activated T lymphocytes with IL-7 <clueType>induces</clueType> a <clueManner>fivefold</clueManner> <clueType>enhanced</clueType> IL-2-mRNA accumulation and a 2.5-fold enhanced protein secretion.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="A13"/>
<clue>Costimulation of phytohemagglutinin/anti-CD28 activated T lymphocytes with IL-7 induces a fivefold enhanced IL-2-mRNA <clueType>accumulation</clueType> and a 2.5-fold enhanced protein secretion.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="E26"/>
<cause idref="E21"/>
<clue>Costimulation of phytohemagglutinin/anti-CD28 activated T lymphocytes with IL-7 <clueType>induces</clueType> a fivefold enhanced IL-2-mRNA accumulation and a 2.5-fold <clueType>enhanced</clueType> protein secretion.</clue>
</event>
<event id="E26">
<type class="Localization"/>
<theme idref="T38"/>
<clue>Costimulation of phytohemagglutinin/anti-CD28 activated T lymphocytes with IL-7 induces a fivefold enhanced IL-2-mRNA accumulation and a 2.5-fold enhanced <corefTheme>protein</corefTheme> <clueType>secretion</clueType>.</clue>
</event>
<sentence id="S6">The <term id="T40" lex="IL-2-gene_transcription_rate" sem="Other"><term id="T41" lex="IL-2-gene" sem="DNA_domain_or_region"><term id="T42" lex="IL-2" sem="Protein_molecule">IL-2</term>-gene</term> transcription rate</term> is increased 3.4-fold, indicating that the effect of <term id="T43" lex="IL-7" sem="Protein_molecule">IL-7</term> is in part mediated at the transcriptional level.</sentence>
<event id="E27">
<type class="Transcription"/>
<theme idref="T41"/>
<clue>The IL-2-gene <clueType>transcription</clueType> rate is increased 3.4-fold, indicating that the effect of IL-7 is in part mediated at the transcriptional level.</clue>
</event>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<clue>The IL-2-gene transcription rate is <clueType>increased</clueType> 3.4-fold, indicating that the effect of IL-7 is in part mediated at the transcriptional level.</clue>
</event>
<event CL="L2" KT="Analysis" id="E29" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="T43"/>
<clue>The IL-2-gene transcription rate is increased 3.4-fold, <clueKT><clueCL>indicating</clueCL></clueKT> that the <clueType>effect</clueType> <linkCause>of</linkCause> IL-7 is in part <clueType>mediated</clueType> <corefTheme>at the transcriptional level</corefTheme>.</clue>
</event>
<sentence id="S7">The molecular mechanisms underlying the <term id="T44" lex="IL-7_effect" sem="Other"><term id="T45" lex="IL-7" sem="Protein_molecule">IL-7</term> effect</term> involve the upregulation of the <term id="A14" sem="DNA_domain_or_region">DNA</term> binding activity of <term id="T46" lex="NFAT" sem="Protein_family_or_group">NFAT</term> (60%) and <term id="T47" lex="AP-1" sem="Protein_molecule">AP-1</term> (120%), without affecting the activities of <term id="T48" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> and <term id="T49" lex="CD28RC" sem="Protein_complex">CD28RC</term>, which was confirmed by <term id="T50" lex="transfection_assay" sem="Other">transfection assays</term>.</sentence>
<event id="E31">
<type class="Regulation"/>
<cause idref="T45"/>
<clue>The molecular mechanisms underlying the IL-7 <clueType>effect</clueType> involve the upregulation of the DNA binding activity of NFAT (60%) and AP-1 (120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
<comment>NO THEME</comment></event>
<event id="E32">
<type class="Regulation"/>
<theme idref="E34"/>
<cause idref="E31"/>
<clue>The molecular mechanisms underlying the IL-7 effect <clueType>involve</clueType> the upregulation of the DNA binding activity of NFAT (60%) and AP-1 (120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
</event>
<event id="E33">
<type class="Regulation"/>
<theme idref="E35"/>
<cause idref="E31"/>
<clue>The molecular mechanisms underlying the IL-7 effect <clueType>involve</clueType> the upregulation of the DNA binding activity of NFAT (60%) and AP-1 (120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<clue>The molecular mechanisms underlying the IL-7 effect involve the <clueType>upregulation</clueType> <linkTheme>of</linkTheme> the DNA binding activity of NFAT (60%) and AP-1 (120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
</event>
<event Manner="High" id="E35">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<clue>The molecular mechanisms underlying the IL-7 effect involve the <clueType>upregulation</clueType> <linkTheme>of</linkTheme> the DNA binding activity of NFAT (60%) and AP-1 (<clueManner>120%</clueManner>), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
</event>
<event id="E36">
<type class="Binding"/>
<theme idref="T46"/>
<theme idref="A14"/>
<clue>The molecular mechanisms underlying the IL-7 effect involve the upregulation of the DNA <clueType>binding</clueType> activity <linkTheme>of</linkTheme> NFAT (60%) and AP-1 (120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
</event>
<event id="E37">
<type class="Binding"/>
<theme idref="T47"/>
<theme idref="A14"/>
<clue>The molecular mechanisms underlying the IL-7 effect involve the upregulation of the DNA <clueType>binding</clueType> activity <linkTheme>of</linkTheme> NFAT (60%) and AP-1 (120%), without affecting the activities of NFkappaB and CD28RC, which was confirmed by transfection assays.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E38">
<type class="Regulation"/>
<theme idref="T48"/>
<cause idref="E31"/>
<clue>The molecular mechanisms underlying the IL-7 effect involve the upregulation of the DNA binding activity of NFAT (60%) and AP-1 (120%), <cluePolarity>without</cluePolarity> <clueType>affecting</clueType> the activities of NFkappaB and CD28RC, which was <clueKT>confirmed</clueKT> <clueExperiment>by transfection assays</clueExperiment>.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E39">
<type class="Regulation"/>
<theme idref="T49"/>
<cause idref="E31"/>
<clue>The molecular mechanisms underlying the IL-7 effect involve the upregulation of the DNA binding activity of NFAT (60%) and AP-1 (120%), <cluePolarity>without</cluePolarity> <clueType>affecting</clueType> the activities of NFkappaB and CD28RC, which was <clueKT>confirmed</clueKT> <clueExperiment>by transfection assays</clueExperiment>.</clue>
</event>
<sentence id="S8">We also show that the <term id="T51" lex="IL-7" sem="Protein_molecule">IL-7</term>-induced enhancement of the <term id="T52" lex="AP-1-DNA_binding_activity" sem="Other"><term id="T53" lex="AP-1" sem="Protein_molecule">AP-1</term>-<term id="A15" sem="DNA_domain_or_region">DNA</term> binding activity</term> is not <term id="T54" lex="cyclosporin_A-sensitive" sem="Other"><term id="A8" sem="Peptide">cyclosporin A</term>-sensitive</term>.</sentence>
<event KT="Other" id="E40">
<type class="Positive_regulation"/>
<theme idref="E41"/>
<cause idref="T51"/>
<clue>We also show that the IL-7<linkCause>-induced</linkCause> <clueType>enhancement</clueType> <linkTheme>of</linkTheme> the AP-1-DNA binding activity is not cyclosporin A-sensitive.</clue>
</event>
<event KT="Other" id="E41">
<type class="Binding"/>
<theme idref="T53"/>
<theme idref="A15"/>
<clue>We also show that the IL-7-induced enhancement of the AP-1-DNA <clueType>binding</clueType> activity is not cyclosporin A-sensitive.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E42">
<type class="Regulation"/>
<theme idref="E40"/>
<cause idref="A8"/>
<clue>We also <clueKT>show</clueKT> that the IL-7-induced enhancement of the AP-1-DNA binding activity is <cluePolarity>not</cluePolarity> cyclosporin A-<clueType>sensitive</clueType>.</clue>
</event>
<sentence id="S9">Since <term id="T55" lex="AP-1" sem="Protein_molecule">AP-1</term> is part of the <term id="T56" lex="NFAT_complex" sem="Protein_complex">NFAT complex</term>, we conclude that the <term id="T57" lex="IL-7-signaling_pathway" sem="Other"><term id="T58" lex="IL-7" sem="Protein_molecule">IL-7</term>-signaling pathway</term> is involved in the activation of the <cons id="T59" lex="(AND fos_protein jun_protein)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F1"><term id="A9" sem="Protein_family_or_group">fos</term></frag> and <frag id="F2"><term id="A10" sem="Protein_family_or_group">jun</term></frag> <frag id="F3"><term id="A11" sem="Protein_family_or_group">proteins</term></frag></cons> of which <term id="T60" lex="AP-1" sem="Protein_molecule">AP-1</term> consists.</sentence>
<event KT="Other" id="E30">
<type class="Cell_communication"/>
<theme idref="T58"/>
<clue>Since AP-1 is part of the NFAT complex, we conclude that the IL-7-<clueType>signaling</clueType> pathway is involved in the activation of the fos and jun proteins of which AP-1 consists.</clue>
</event>
<event KT="Analysis" id="E43">
<type class="Regulation"/>
<theme idref="E45"/>
<cause idref="E30"/>
<clue>Since AP-1 is part of the NFAT complex, we <clueKT>conclude</clueKT> that the IL-7-signaling pathway is <clueType>involved</clueType> <linkTheme>in</linkTheme> the activation of the fos and jun proteins of which AP-1 consists.</clue>
</event>
<event KT="Analysis" id="E44">
<type class="Regulation"/>
<theme idref="E46"/>
<cause idref="E30"/>
<clue>Since AP-1 is part of the NFAT complex, we <clueKT>conclude</clueKT> that the IL-7-signaling pathway is <clueType>involved</clueType> <linkTheme>in</linkTheme> the activation of the fos and jun proteins of which AP-1 consists.</clue>
</event>
<event KT="Other" id="E45">
<type class="Positive_regulation"/>
<theme idref="A9" idref1="A11"/>
<clue>Since AP-1 is part of the NFAT complex, we conclude that the IL-7-signaling pathway is involved in the <clueType>activation</clueType> <linkTheme>of</linkTheme> the fos and jun proteins of which AP-1 consists.</clue>
</event>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<cause idref="A10" idref1="A11"/>
<clue>Since AP-1 is part of the NFAT complex, we conclude that the IL-7-signaling pathway is involved in the <clueType>activation</clueType> <linkTheme>of</linkTheme> the fos and jun proteins of which AP-1 consists.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
